DNRS 6630 Week 6 Treatment Plan Example

Psychopharmacologic Approaches to Treatment of Psychopathology Walden University Free custom sample in 24 to 48h

This DNRS 6630 Week 6 treatment plan example is written so someone else can check it. She is a composite 52-year-old school administrator in a first episode of major depression with insomnia, PHQ-9 score 18. The plan orders the problem list, names each target symptom with the instrument that will measure it, records the treatment decision, and sets monitoring with dates and thresholds, including suicide risk screening with the Columbia scale. A contingency section says what happens if the first choice fails, and education is written to be confirmed back by the patient. Walden DNRS 6630, Psychopharmacologic Approaches to Treatment of Psychopathology, asks DNP students for a plan with this level of specificity. Sources include Cipriani's antidepressant network meta-analysis, Cuijpers on psychotherapy, and the Insomnia Severity Index validation paper.

CourseDNRS 6630 Psychopharmacologic Approaches to Treatment of Psychopathology
WeekWeek 6
Paper typeTreatment plan
LengthAbout 750 words, 5 pages
FormatAPA 7 student paper
SchoolWalden University
ProgramDoctor of Nursing Practice (DNP)
UpdatedOctober 2026

Free sample paper for DNRS 6630 Week 6

1

Treatment Plan: A First Episode of Major Depression With Insomnia in a 52-Year-Old Woman, Written So It Can Be Checked

Student Name

College of Nursing, Walden University

DNRS 6630: Psychopharmacologic Approaches to Treatment of Psychopathology

Instructor Name

Month Day, Year

What this page is doingThe title says the plan is written to be checked. Plans in this course are graded as commitments, and the title tells the reader to look for measures, owners and dates.
2

Treatment Plan: A First Episode of Major Depression With Insomnia in a 52-Year-Old Woman, Written So It Can Be Checked

Problem List

Composite patient: a 52-year-old woman, a school administrator, with her first episode of major depression over 3 months. Problems are ordered by what is addressed first. 1. Major depressive disorder, single episode, moderately severe; PHQ-9 score 18. 2. Insomnia, mainly early waking, secondary to problem 1 and worsening it. 3. Passive thoughts of death without plan or intent; screened today. 4. Reduced work function: 6 sick days in the past month. 5. Hypertension, controlled, relevant to monitoring.

Target Symptoms and How Each Will Be Measured

Each target has an instrument or observation, which is what makes the rest of the plan checkable. Depressed mood, loss of interest, and related symptoms: PHQ-9 total score (Kroenke et al., 2001). Sleep: Insomnia Severity Index (Bastien et al., 2001). Suicidal thoughts: the Columbia-Suicide Severity Rating Scale in its brief screen form (Posner et al., 2011). Work function: sick days per month, reported by her. Blood pressure: seated reading at each visit.

What this page is doingPairing every target with a measure is the section that makes the whole plan checkable. A target without a measure is an intention.
3

The Decision

The plan combines an antidepressant from the serotonin reuptake inhibitor class with a referral for cognitive behavioral therapy. The combination is chosen because a network meta-analysis of psychotherapy, pharmacotherapy, and their combination in adult depression found combined treatment more effective than either alone (Cuijpers et al., 2020), and because her severity, her sleep disturbance, and her passive thoughts of death argue for not relying on psychotherapy alone while she waits for a first appointment. Within medication, the reuptake inhibitor class is chosen for its balance of efficacy and acceptability in a large network meta-analysis of antidepressants (Cipriani et al., 2018) and because it does not worsen her blood pressure. The specific agent, amount, and adjustment schedule are set in the prescription, not in this plan.

Two alternatives were considered. Psychotherapy alone is a reasonable first choice for many people with depression, and she would prefer to avoid medication if she could. It was not chosen alone because the earliest therapy appointment is 5 weeks away and her sleep and work function are worsening now. A separate sleep medication was also considered for the insomnia, and set aside: her early waking is part of the depression, it is expected to improve as the depression does, and adding a sedative would add fall and next-day risks without treating the cause. If her sleep has not improved by week 4, that decision is revisited with her.

Monitoring

Table 1 sets out what is checked, when, and by whom.

Table 1

Monitoring Table

What is checkedWhenWho checks it
Side effects, sleep, missed doses in the last 7 daysWeek 2, by phoneClinic nurse
C-SSRS screenWeek 2 phone call and every visitClinic nurse; nurse practitioner
PHQ-9 and Insomnia Severity IndexWeeks 4, 8, and 12Nurse practitioner
Blood pressureEvery visitMedical assistant
Sick days in the past monthEvery visitNurse practitioner, from her report
Therapy attendanceWeek 4 and week 8Care coordinator

Contingency

The observation that triggers a change is a PHQ-9 score that has fallen by less than 20% at week 4 or less than 50% at week 8 despite adherence and a tolerated dose. The change, in general terms, is to review adherence and side effects first, then to adjust within the class, switch to another class, or intensify psychotherapy, chosen with her. Any C-SSRS answer indicating active thoughts with method, intent, or plan triggers same-day safety assessment, regardless of the scheduled date.

Education, Written to Be Confirmed Back

She is asked to explain each point back in her own words before leaving. 1. Benefit usually builds over several weeks; early side effects often ease in the first 2. 2. Stopping suddenly can cause unpleasant symptoms, so any wish to stop is discussed first. 3. If thoughts of death become thoughts of acting, she calls the crisis line or the clinic the same day; she can say where the number is kept. 4. Sleep habits from therapy are part of the treatment, not an extra. 5. The nurse will call in 2 weeks and will ask how many days she missed; an honest number is more useful than a good one.

Follow-Up

Phone check at 2 weeks, visit at 4 weeks, then at 8 and 12 weeks. The 2-week interval is set because side effects and stopping are most likely early, and because her passive thoughts of death call for early contact rather than a routine month.

What this page is doingThe follow-up interval carries its reason. Every part of the plan can be checked later by someone who was not in the room.
4

References

Bastien, C. H., Vallières, A., & Morin, C. M. (2001). Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Medicine, 2(4), 297-307. https://doi.org/10.1016/S1389-9457(00)00065-4

Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., Egger, M., Takeshima, N., Hayasaka, Y., Imai, H., Shinohara, K., Tajika, A., Ioannidis, J. P. A., & Geddes, J. R. (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis. The Lancet, 391(10128), 1357-1366. https://doi.org/10.1016/S0140-6736(17)32802-7

Cuijpers, P., Noma, H., Karyotaki, E., Vinkers, C. H., Cipriani, A., & Furukawa, T. A. (2020). A network meta-analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression. World Psychiatry, 19(1), 92-107. https://doi.org/10.1002/wps.20701

Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606-613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x

Posner, K., Brown, G. K., Stanley, B., Brent, D. A., Yershova, K. V., Oquendo, M. A., Currier, G. W., Melvin, G. A., Greenhill, L., Shen, S., & Mann, J. J. (2011). The Columbia-Suicide Severity Rating Scale: Initial validity and internal consistency findings from three multisite studies with adolescents and adults. The American Journal of Psychiatry, 168(12), 1266-1277. https://doi.org/10.1176/appi.ajp.2011.10111704

The Walden DNRS 6630 Week 6 instructions

The sixth week often asks for a full treatment plan for a patient with a psychiatric diagnosis. The plan usually needs a problem list, target symptoms, a treatment choice with rationale, monitoring, a plan for nonresponse or adverse effects, patient education and follow-up timing. DNRS 6630 faculty want each element to be checkable, so measures and intervals should be named rather than implied. Expect a structured APA 7 document, frequently five pages or so, citing guideline or comparative evidence for the decision. Validated rating scales strengthen the target symptom section. Some sections leave out medication specifics so the plan is judged on structure; read the prompt for whether agents should be named. Safety screening belongs in the plan wherever the diagnosis carries suicide risk.

Inside the DNRS 6630 Week 6 example

Seven parts hold the document together. A problem list orders what is being addressed first. Target symptoms follow, each paired with the instrument or observation that will measure it, and this is the section that makes everything after it checkable. The decision paragraph commits and justifies itself against the presenting picture, citing guidance rather than a tertiary reference. A monitoring table carries three columns: what is checked, when, and who checks it. A contingency section names the observation that would trigger a change and describes that change in general terms. An education section is written as points to be confirmed back. A follow-up interval closes with a reason attached. Nothing on this page names a compound, states a quantity, or sets out a schedule for adjusting one.

Reading the DNRS 6630 Week 6 rubric

The monitoring area is where plans lose most, and the phrase that costs it is any general assurance about watching for adverse effects. What earns instead is a schedule specific enough that somebody could audit it. Targets without measures damage two areas at once, since an unmeasurable target makes the evaluation section unwritable. Missing contingency is the second frequent loss, and markers read its absence as a plan that thought only about starting. Education sections written as warnings collect little, because nothing in them shows the writer checking that anything landed. Source hierarchy is graded here, with guidance and primary literature earning where a package summary does not. Internal inconsistency is caught fast, particularly a monitoring row for something the plan never actually included.

DNRS 6630 Week 6 help from the desk

The phrase that costs most here is a general promise to watch for adverse effects. Replace it with the check itself, the person responsible, its date and the result that would alter course. Another problem is target symptoms with no measure attached, so improvement could never be shown. Writers also skip the contingency section or fill it with "consider switching," which is not a plan. State the first fallback and the trigger for it. Keep insomnia as its own problem if the case lists it, since it needs its own measure. Education written as a paragraph of advice is hard to confirm; write it as points the patient can repeat. Check that scale scores and severity bands match the cited validation papers.

Get a DNRS 6630 Week 6 example written to your instructions

Send the plan template your section distributes, the case it assigns and the rubric attached to it, and a completed document in that template comes back to you. The first custom one is free, turned around in 24 to 48 hours. The plan you receive shows structure and sourcing; prescribing specifics stay with the supervising clinician who is accountable for them.

More DNRS 6630 papers and DNP samples

DNRS 6630 Week 6 questions, answered

Why does the example carry no medication particulars?

Because those belong in a supervised classroom rather than on a page anyone can open, and because the writing problem this week sets is structural. What makes a plan strong is measurable targets, an auditable monitoring schedule and a stated rule for changing course. Those are visible without any product on the page, and they are the parts most submissions get wrong.

How specific does a monitoring schedule have to be?

Specific enough that a colleague reading it a month later could tell whether it was followed. That means naming what is checked, the interval, and who is responsible, which is why the example uses a table. Some sections supply their own monitoring format, and where they do, the required fields replace this arrangement entirely.

Does the plan need an evaluation section as well?

Many prompts ask for one, and where they do it depends entirely on the targets section, because evaluation is just those measures read at a later date. If the targets carry instruments, the evaluation section almost writes itself. If they do not, the section becomes a paragraph of impressions, which is where the credit for it disappears.

Where can I find a free DNRS 6630 Week 6 sample paper?

This page reproduces the depression with insomnia plan from the problem list to follow-up, including the monitoring dates, the contingency step and the teach-back education.

What should a DNRS 6630 Week 6 monitoring section include?

Named measures, intervals and thresholds. The example rechecks the PHQ-9 and Insomnia Severity Index on set dates, screens suicide risk each visit, and says which result triggers a change.